Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Decker

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2022
Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional ModelSarah J Gao, Lan Jin, Hugh W Meadows, et al.
Iscience|July 21, 2025
Interleukin-6 in synovial fluid drives the conversion of DC2s to DC3s in inflammatory arthritisAnnika H Decker, Lucas L van den Hoogen, Tom van Oorschot, et al.
Journal of the American Academy of Dermatology|July 21, 2018
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapyJacob Siegel, Mariam Totonchy, William Damsky, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyJohn M Stahl, Rudi Ross, Eileen M Harder, et al.
Head & Neck|February 4, 2020
Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerNadia A Saeed, Jacqueline R Kelly, Hari A Deshpande, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional AnalysisVivek Verma, Valerie K Shostrom, Weining Zhen, et al.
Plos One|April 25, 2013
Derivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured ratNathan C Manley, Javier R Caso, Melissa G Works, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNASarah B Goldberg, Azeet Narayan, Adam J Kole, et al.
Clinical Lung Cancer|March 22, 2021
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)Athanassios Argiris, Jieling Miao, Mihaela C Cristea, et al.
Journal of Radiosurgery and SBRT|August 18, 2020
Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapyJoseph A Miccio, Andrew Barsky, Sarah Gao, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2022
Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and External Validation of a Multi-Institutional ModelSarah J Gao, Lan Jin, Hugh W Meadows, et al.
Iscience|July 21, 2025
Interleukin-6 in synovial fluid drives the conversion of DC2s to DC3s in inflammatory arthritisAnnika H Decker, Lucas L van den Hoogen, Tom van Oorschot, et al.
Journal of the American Academy of Dermatology|July 21, 2018
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapyJacob Siegel, Mariam Totonchy, William Damsky, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2016
The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyJohn M Stahl, Rudi Ross, Eileen M Harder, et al.
Head & Neck|February 4, 2020
Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerNadia A Saeed, Jacqueline R Kelly, Hari A Deshpande, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional AnalysisVivek Verma, Valerie K Shostrom, Weining Zhen, et al.
Plos One|April 25, 2013
Derivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured ratNathan C Manley, Javier R Caso, Melissa G Works, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2018
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNASarah B Goldberg, Azeet Narayan, Adam J Kole, et al.
Clinical Lung Cancer|March 22, 2021
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811)Athanassios Argiris, Jieling Miao, Mihaela C Cristea, et al.
Journal of Radiosurgery and SBRT|August 18, 2020
Multi-institutional retrospective review of stereotactic radiosurgery for brain metastasis in patients with small cell lung cancer without prior brain-directed radiotherapyJoseph A Miccio, Andrew Barsky, Sarah Gao, et al.
Pageof 30